Androgen Suppression Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With High-Risk Localized Prostate Cancer

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Prostate Cancer
2		Additional conditions recognized in this trial
			Prostatic Neoplasms
3		More general conditions related to this trial
			Genital Diseases, Male
			Genital Neoplasms, Male
			Neoplasms
			Neoplasms by Site
			Prostatic Diseases
			Urogenital Neoplasms
4		Interventions listed in this trial
			bicalutamide
			buserelin
			docetaxel
			flutamide
			goserelin
			leuprolide acetate
			neoadjuvant therapy
			quality-of-life assessment
			radiation therapy
5		Additional drug interventions recognized in this trial
			Leuprolide
6		More general drug interventions related to this trial
			Androgen Antagonists
			Antineoplastic Agents
			Antineoplastic Agents, Hormonal
			Fertility Agents
			Fertility Agents, Female
			Hormone Antagonists
			Hormones, Hormone Substitutes, and Hormone Antagonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Reproductive Control Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			National Cancer Institute of Canada
			National Cancer Institute (NCI)